−3.0TWD
−915.21 MTWD
1.02 BTWD
211.70 M
About EIRGENIX INC
Sector
Industry
CEO
Li Cheng Liu
Website
Headquarters
New Taipei
Founded
2012
ISIN
TW0006589005
FIGI
BBG00F9WQ1D1
EirGenix, Inc. engages in the research and development of biotechnology drugs. Its products and services include Trastuzumab Biosimilar, Pertuzumab Biosimilar, New Formulation, Antibody-Drug Conjugate, Bevacizumab Biosimilar, CRM197 Carrier Protein, and Biosimilar. The company was founded by Li Cheng Liu on December 21, 2012 and is headquartered in New Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6589 is 77.0 TWD — it has decreased by 4.47% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange EIRGENIX INC stocks are traded under the ticker 6589.
EIRGENIX INC is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
6589 stock is 5.36% volatile and has beta coefficient of 0.13. Check out the list of the most volatile stocks — is EIRGENIX INC there?
One year price forecast for EIRGENIX INC has a max estimate of 133.0 TWD and a min estimate of 130.0 TWD.
6589 earnings for the last quarter are −0.37 TWD per share, whereas the estimation was −0.49 TWD resulting in a 24.44% surprise. The estimated earnings for the next quarter are −0.13 TWD per share. See more details about EIRGENIX INC earnings.
EIRGENIX INC revenue for the last quarter amounts to 138.00 M TWD despite the estimated figure of 138.00 M TWD. In the next quarter revenue is expected to reach 189.50 M TWD.
Yes, you can track EIRGENIX INC financials in yearly and quarterly reports right on TradingView.
6589 stock has fallen by 10.67% compared to the previous week, the month change is a 11.39% fall, over the last year EIRGENIX INC has showed a 36.63% decrease.
6589 net income for the last quarter is −405.94 M TWD, while the quarter before that showed −111.72 M TWD of net income which accounts for −263.35% change. Track more EIRGENIX INC financial stats to get the full picture.
Today EIRGENIX INC has the market capitalization of 24.48 B, it has decreased by 1.38% over the last week.
No, 6589 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6589 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EIRGENIX INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EIRGENIX INC technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EIRGENIX INC stock shows the strong sell signal. See more of EIRGENIX INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on EIRGENIX INC future price: according to them, 6589 price has a max estimate of 133.00 TWD and a min estimate of 130.00 TWD. Read a more detailed EIRGENIX INC forecast: see what analysts think of EIRGENIX INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EIRGENIX INC EBITDA is −793.14 M TWD, and current EBITDA margin is −77.56%. See more stats in EIRGENIX INC financial statements.